Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantation

Bone Marrow Transplant. 2022 Jul;57(7):1198-1200. doi: 10.1038/s41409-022-01692-9. Epub 2022 May 2.

Affiliations

¹ Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
² Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. tadakazu@kuhp.kyoto-u.ac.jp.
³ Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
⁴ Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.

PMID: 35501566
DOI: 10.1038/s41409-022-01692-9

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bone Marrow Transplantation
Cyclosporine / therapeutic use
Drug Monitoring
Graft vs Host Disease* / drug therapy
Graft vs Host Disease* / prevention & control
Hematopoietic Stem Cell Transplantation*
Humans
Immunosuppressive Agents / therapeutic use
Mycophenolic Acid / therapeutic use

Substances

Immunosuppressive Agents
Cyclosporine
Mycophenolic Acid